—
RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and better than antisense technology for gene suppression.
Scope of the Report:
This report focuses on the RNAi for Therapeutic in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Get Sample Report @ https://www.wiseguyreports.com/sample-request/731692-global-rnai-for-therapeutic-forecast-to-2021
For more information or any query mail at sales@wiseguyreports.com
Market Segment by Manufacturers, this report covers
Alnylam Pharmaceuticals
Arbutus Biopharma (Tekmira)
Arrowhead
Dicerna Pharmaceuticals
Mirna Therapeutics
Quark Pharmaceuticals
RXi Pharmaceuticals
Silence Therapeutics
Benitec Biopharma
miRagen Therapeutics
Sylentis
Gradalis
Sirnaomics
Silenseed
Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America, Middle East and Africa
Market Segment by Type, covers
siRNA
miRNA
shRNA
Market Segment by Applications, can be divided into
Cancer
Cardiovascular
HBV
Other
Complete Report Details @ https://www.wiseguyreports.com/reports/731692-global-rnai-for-therapeutic-forecast-to-2021
Table Of Contents – Major Key Points
Global RNAi for Therapeutic Market by Manufacturers, Regions, Type and Application, Forecast to 2021
1 Market Overview
1.1 RNAi for Therapeutic Introduction
1.2 Market Analysis by Type
1.2.1 siRNA
1.2.2 miRNA
1.2.3 shRNA
1.3 Market Analysis by Applications
1.3.1 Cancer
1.3.2 Cardiovascular
1.3.3 HBV
1.4 Market Analysis by Regions
1.4.1 North America (USA, Canada and Mexico)
1.4.1.1 USA
1.4.1.2 Canada
1.4.1.3 Mexico
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany
1.4.2.2 France
1.4.2.3 UK
1.4.2.4 Russia
1.4.2.5 Italy
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China
1.4.3.2 Japan
1.4.3.3 Korea
1.4.3.4 India
1.4.3.5 Southeast Asia
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil
1.4.4.2 Egypt
1.4.4.3 Saudi Arabia
1.4.4.4 South Africa
1.4.4.5 Nigeria
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Alnylam Pharmaceuticals
2.1.1 Business Overview
2.1.2 RNAi for Therapeutic Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Alnylam Pharmaceuticals RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share
2.2 Arbutus Biopharma (Tekmira)
2.2.1 Business Overview
2.2.2 RNAi for Therapeutic Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Arbutus Biopharma (Tekmira) RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share
2.3 Arrowhead
2.3.1 Business Overview
2.3.2 RNAi for Therapeutic Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Arrowhead RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share
2.4 Dicerna Pharmaceuticals
2.4.1 Business Overview
2.4.2 RNAi for Therapeutic Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Dicerna Pharmaceuticals RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share
2.5 Mirna Therapeutics
2.5.1 Business Overview
2.5.2 RNAi for Therapeutic Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Mirna Therapeutics RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share
2.6 Quark Pharmaceuticals
2.6.1 Business Overview
2.6.2 RNAi for Therapeutic Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Quark Pharmaceuticals RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share
2.7 RXi Pharmaceuticals
2.7.1 Business Overview
2.7.2 RNAi for Therapeutic Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 RXi Pharmaceuticals RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share
2.8 Silence Therapeutics
2.8.1 Business Overview
2.8.2 RNAi for Therapeutic Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Silence Therapeutics RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share
2.9 Benitec Biopharma
2.9.1 Business Overview
2.9.2 RNAi for Therapeutic Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Benitec Biopharma RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share
2.10 miRagen Therapeutics
2.10.1 Business Overview
2.10.2 RNAi for Therapeutic Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 miRagen Therapeutics RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share
2.11 Sylentis
2.11.1 Business Overview
2.11.2 RNAi for Therapeutic Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 Sylentis RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share
2.12 Gradalis
2.12.1 Business Overview
2.12.2 RNAi for Therapeutic Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 Gradalis RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share
2.13 Sirnaomics
2.13.1 Business Overview
2.13.2 RNAi for Therapeutic Type and Applications
2.13.2.1 Type 1
2.13.2.2 Type 2
2.13.3 Sirnaomics RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share
2.14 Silenseed
2.14.1 Business Overview
2.14.2 RNAi for Therapeutic Type and Applications
2.14.2.1 Type 1
2.14.2.2 Type 2
2.14.3 Silenseed RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share
3 Global RNAi for Therapeutic Market Competition, by Manufacturer
3.1 Global RNAi for Therapeutic Sales and Market Share by Manufacturer
3.2 Global RNAi for Therapeutic Revenue and Market Share by Manufacturer
3.3 Market Concentration Rate
3.3.1 Top 3 RNAi for Therapeutic Manufacturer Market Share
3.3.2 Top 6 RNAi for Therapeutic Manufacturer Market Share
3.4 Market Competition Trend
4 Global RNAi for Therapeutic Market Analysis by Regions
4.1 Global RNAi for Therapeutic Sales, Revenue and Market Share by Regions
4.1.1 Global RNAi for Therapeutic Sales by Regions (2011-2016)
4.1.2 Global RNAi for Therapeutic Revenue by Regions (2011-2016)
4.2 North America RNAi for Therapeutic Sales and Growth (2011-2016)
4.3 Europe RNAi for Therapeutic Sales and Growth (2011-2016)
4.4 Asia-Pacific RNAi for Therapeutic Sales and Growth (2011-2016)
4.5 South America RNAi for Therapeutic Sales and Growth (2011-2016)
4.6 Middle East and Africa RNAi for Therapeutic Sales and Growth (2011-2016)
5 North America RNAi for Therapeutic by Countries
..……CONTINUED
For more information or any query mail at sales@wiseguyreports.com
Buy 1-User PDF @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=731692
ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.
Contact Info:
Name: Norah Trent
Email: Send Email
Organization: WiseGuy Research Consultants Pvt Ltd.
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune - 411028
Phone: +1-646-845-9349
Website: https://www.wiseguyreports.com
Release ID: 144598
Google
RSS